Amorphous sparsentan compositions

An amorphous form of a compound having structure (I), or a pharmaceutically acceptable salt thereof, is provided. Such compounds may be used for the treatment of kidney diseases or disorders.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: HULVAT, James Francis, WU, Xiangming, MACIKENAS, Dainius, RUBY, Kale
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator HULVAT, James Francis
WU, Xiangming
MACIKENAS, Dainius
RUBY, Kale
description An amorphous form of a compound having structure (I), or a pharmaceutically acceptable salt thereof, is provided. Such compounds may be used for the treatment of kidney diseases or disorders.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_AU2019404552A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AU2019404552A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_AU2019404552A13</originalsourceid><addsrcrecordid>eNrjZFB0zM0vKsjILy1WKC5ILCpOzStJzFNIzs8tyC_OLMnMzyvmYWBNS8wpTuWF0twMym6uIc4euqkF-fGpQE3JqXmpJfGOoUYGhpYmBiampkaOhsbEqQIAaPwnPA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Amorphous sparsentan compositions</title><source>esp@cenet</source><creator>HULVAT, James Francis ; WU, Xiangming ; MACIKENAS, Dainius ; RUBY, Kale</creator><creatorcontrib>HULVAT, James Francis ; WU, Xiangming ; MACIKENAS, Dainius ; RUBY, Kale</creatorcontrib><description>An amorphous form of a compound having structure (I), or a pharmaceutically acceptable salt thereof, is provided. Such compounds may be used for the treatment of kidney diseases or disorders.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20210715&amp;DB=EPODOC&amp;CC=AU&amp;NR=2019404552A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20210715&amp;DB=EPODOC&amp;CC=AU&amp;NR=2019404552A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>HULVAT, James Francis</creatorcontrib><creatorcontrib>WU, Xiangming</creatorcontrib><creatorcontrib>MACIKENAS, Dainius</creatorcontrib><creatorcontrib>RUBY, Kale</creatorcontrib><title>Amorphous sparsentan compositions</title><description>An amorphous form of a compound having structure (I), or a pharmaceutically acceptable salt thereof, is provided. Such compounds may be used for the treatment of kidney diseases or disorders.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFB0zM0vKsjILy1WKC5ILCpOzStJzFNIzs8tyC_OLMnMzyvmYWBNS8wpTuWF0twMym6uIc4euqkF-fGpQE3JqXmpJfGOoUYGhpYmBiampkaOhsbEqQIAaPwnPA</recordid><startdate>20210715</startdate><enddate>20210715</enddate><creator>HULVAT, James Francis</creator><creator>WU, Xiangming</creator><creator>MACIKENAS, Dainius</creator><creator>RUBY, Kale</creator><scope>EVB</scope></search><sort><creationdate>20210715</creationdate><title>Amorphous sparsentan compositions</title><author>HULVAT, James Francis ; WU, Xiangming ; MACIKENAS, Dainius ; RUBY, Kale</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_AU2019404552A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2021</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>HULVAT, James Francis</creatorcontrib><creatorcontrib>WU, Xiangming</creatorcontrib><creatorcontrib>MACIKENAS, Dainius</creatorcontrib><creatorcontrib>RUBY, Kale</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>HULVAT, James Francis</au><au>WU, Xiangming</au><au>MACIKENAS, Dainius</au><au>RUBY, Kale</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Amorphous sparsentan compositions</title><date>2021-07-15</date><risdate>2021</risdate><abstract>An amorphous form of a compound having structure (I), or a pharmaceutically acceptable salt thereof, is provided. Such compounds may be used for the treatment of kidney diseases or disorders.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_AU2019404552A1
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Amorphous sparsentan compositions
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T00%3A32%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=HULVAT,%20James%20Francis&rft.date=2021-07-15&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EAU2019404552A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true